(Effective January 22, 2027)
Unless the context clearly requires otherwise, the following definitions, as well as the definitions in WAC 246-945-001, apply for the purposes of WAC 246-945-026 through 246-945-029:
(1) "Accessible prescription information" means the provision of accurate prescription information to a visually impaired or print disabled individual, and means the provision of accurate complete directions for use to an individual with LEP.
(2) "Complete directions for use" means standard instructions intended to guide a patient on how to safely and effectively use a dispensed prescription. Minimum elements include:
(a) The verb such as, but not limited to, take, place, instill;
(b) The dosage form such as, but not limited to, tablet, capsule, and drops;
(c) Dosage quantity;
(d) Route of administration;
(e) Frequency of administration; and
(f) Additional contextual information for the safe and effective use of a dispensed prescription such as, but not limited to, "as needed," and "when tired."
(3) "Dispensing facility" or "dispensing facilities" means a pharmacy, nonresident pharmacy, healthcare entity, or hospital pharmacy associated clinic that dispenses and delivers prescriptions to the ultimate user or the ultimate user's authorized representative. It does not include prescriptions dispensed by a pharmacy, nonresident pharmacy, healthcare entity, and hospital pharmacy associated clinic that are administered by a licensed healthcare professional acting within their scope of practice.
(4) "Dispensing practitioner" or "dispensing practitioners" means a practitioner authorized to prescribe legend drugs and who dispenses and delivers prescriptions directly to the ultimate user or the ultimate user's authorized representative.
(5) "External accessible device" means a commercially available computer, mobile phone, or other communications device that is able to receive electronic information transmitted from an external source and provide the electronic information in a form and format accessible to the individual.
(6) "Individual with limited-English proficiency" or "individual with LEP" means a person who does not speak English as their primary language and who has a limited ability to read, speak, write, or understand English.
(7) "Means of access" means provision of a mechanism to enable a visually impaired or print disabled individual to receive accurate prescription information.
(8) "Oral interpretation" means oral communication in which a person acting as an interpreter comprehends a message and re-expresses all necessary information accurately in the individual with LEP's preferred language.
(9) "Prescription information" means drug or device name, patient name, patient species if applicable, complete directions for use, and drug quantity.
(10) "Prescription drug reader" means a device that provides information in an audio format accessible to the individual.
(11) "Print disabled" means the inability to effectively read or access prescription information due to a visual, physical, perceptual, cognitive disability, or other impairment.
(12) "QR code" means a two-dimensional barcode printed as a square pattern of black and white squares that encodes data.
(13) "Translation" shall mean the accurate conversion of a written text from one language into an equivalent written text in another language.
(14) "Visually impaired" means an impairment that prevents an individual from effectively reading or accessing information, such as prescription information, without assistance.